Delix Therapeutics raises $70m
The round in the neuroscience company was led by ARTIS Ventures, RA Capital Management and founding investor OMX Ventures.
27 September 2021•1 min read
The round in the neuroscience company was led by ARTIS Ventures, RA Capital Management and founding investor OMX Ventures.